CORELLI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 10.716
EU - Europa 8.874
AS - Asia 1.352
OC - Oceania 23
SA - Sud America 21
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.004
Nazione #
US - Stati Uniti d'America 10.683
GB - Regno Unito 2.758
IE - Irlanda 1.629
CN - Cina 1.202
UA - Ucraina 1.029
IT - Italia 915
SE - Svezia 824
FR - Francia 683
DE - Germania 579
FI - Finlandia 279
TR - Turchia 74
ES - Italia 33
RU - Federazione Russa 30
CA - Canada 27
BE - Belgio 24
AU - Australia 22
IN - India 16
CL - Cile 13
PL - Polonia 13
RO - Romania 13
VN - Vietnam 13
NL - Olanda 11
AT - Austria 8
JP - Giappone 8
CZ - Repubblica Ceca 7
HK - Hong Kong 7
SI - Slovenia 6
BR - Brasile 5
EE - Estonia 5
EG - Egitto 5
PK - Pakistan 5
ZA - Sudafrica 5
CH - Svizzera 4
EU - Europa 4
IR - Iran 4
KR - Corea 4
SA - Arabia Saudita 4
BG - Bulgaria 3
HU - Ungheria 3
IM - Isola di Man 3
LK - Sri Lanka 3
MX - Messico 3
SG - Singapore 3
AL - Albania 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
Totale 21.004
Città #
Southend 2.585
Dublin 1.626
Fairfield 1.505
Menlo Park 1.467
Jacksonville 846
Chandler 815
Woodbridge 720
Ashburn 654
Wilmington 642
Houston 544
Cambridge 498
Seattle 497
Ann Arbor 347
Beijing 303
Princeton 295
Siena 294
Nanjing 289
Nanchang 124
Boardman 114
Helsinki 106
San Diego 95
San Mateo 92
Fremont 84
Shenyang 65
New York 64
Izmir 61
Hebei 53
Tianjin 53
Florence 49
Düsseldorf 44
Shanghai 42
Dearborn 41
Norwalk 40
Venezia 40
London 37
Changsha 36
Rome 36
Milan 34
Jiaxing 31
Kunming 30
Lancaster 29
Redwood City 23
Brussels 22
Hangzhou 22
Málaga 22
Anguillara Sabazia 20
Guangzhou 20
Jinan 19
San Francisco 19
Ningbo 18
Zhengzhou 16
Changchun 12
Dong Ket 12
Melbourne 11
Naples 11
Washington 11
Mestre 10
Philadelphia 10
Rende 10
Taizhou 10
Mogliano 9
Urlati 9
Bonndorf 8
Candiolo 8
Kilburn 8
Lanzhou 8
Saint Petersburg 8
Toronto 8
Vienna 8
Aligarh 7
Cardiff 7
Chicago 7
Montréal 7
Tappahannock 7
Bari 6
Galatone 6
Haikou 6
Hefei 6
Indiana 6
Latina 6
Los Angeles 6
Sydney 6
Certaldo 5
Edinburgh 5
Frankfurt am Main 5
Livorno 5
Madrid 5
Mestrino 5
Montreal 5
Paris 5
Tallinn 5
Valencia 5
Arconate 4
Atlanta 4
Como 4
Fucecchio 4
Hong Kong 4
Konstanz 4
Krakow 4
Leawood 4
Totale 15.864
Nome #
Ligandi TRPV1 301
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 270
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 217
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 197
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach. 196
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 188
null 186
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 184
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury 172
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 166
Synthesis of an original oxygenated taxuspine X analogue: a versatile non-natural natural product with remarkable P-gp modulating activity 165
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains. 164
Antifungal agents. 10. New derivatives of 1-[(Aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-Candida activity and Quantitative Structure-Analysis Relationship studies 161
Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy 160
Synthesis, 1 structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof 157
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 156
Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity 153
Simplified Analogues of Immucillin-G Retain Potent Human Purine Nucleoside Phosphorylase Inhibitory Activity 152
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 151
Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors. 148
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 147
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 147
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 144
Anxiety-like behaviors at the end of the nocturnal period in sP rats with a “history” of unpredictable, limited access to alcohol. 144
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure-Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors. 144
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 143
Synthesis and Interaction with Copper(II) Cations of Cyano- and Aminoresorcin[4]arenes 142
Synthesis of reactive cytidine derivatives as building blocks for cross-linking oligonucleotides 142
NUOVA TERAPIA PER IL TRATTAMENTO DELL'IPERURICEMIA NELLA SINDROME DI LESCH-NYHAN 141
Parallel solution phase synthesis of 4-dialkylamino-2-methylsulfonyl-6-vinylpyrimidines 140
Microwave-enhanced Sonogashira coupling reaction of substituted pyrimidinones and pyrimidine nucleosides 140
Solid-phase synthesis (SPS) of substituted uracils via Oxone® cleavage methodology 140
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 140
Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones 140
Synthesis, molecular modeling studies, and pharmacological activity of selective A1 receptor antagonists 140
Solid phase synthesis of 5,6-disubstituted pyrimidinone and pyrimidindione derivatives 139
Pyrrolobenzodiazepines and related systems. 2. Synthesis and biological properties of isonoraptazepine derivatives 139
Chiral Azole Derivatives, 3. Synthesis of the Enantiomers of the Potent Aromatase Inhibitor 1-[2-Benzofuranyl(4-chlorophenyl)methyl]-1H-imidazole 139
Inhibition of alcohol self-administration by positive allosteric modulators of the GABA(B) receptor in rats: lack of tolerance and potentiation of baclofen 139
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 139
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors 137
Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle 136
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 136
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 135
Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice 133
A Novel Route to Calix[4]arenes. 2. Solution- and Solid-State Structural Analyses and Molecular Modeling Studies 133
Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies. 133
Design, Synthesis, and Pharmacological Characterization of Indole-3-ylacetamides, Indole-3-yloxoacetamides, and Indole-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 132
Polycondensed heterocycles. V. Synthesis of 5H,11H-Pyrrolo[2,1-c][1,4]benzothiazepine 130
Probing the substrate specificity for lipases. II. Kinetic and Modeling Studies on the Molecular Recognition of 2-Arylpropionic Esters by Candida rugosa and Rhizomucor miehei Lipases 130
Antifungal Agents. 11.N-Substituted Derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3yl)methyl]-1H-imidazole: Synthesis, Anti-Candida Activity, and QSAR Studies 129
Novel Substituted Aminoalkylguanidines as Potential Antihyperglycemic and Food Intake-Reducing Agents. 129
An improved synthesis of solid-supported reagents (SSRs) for selective acylation of amines by microwave irradiation 128
Probing the substrate specificity for lipases. A CoMFA approach for predicting the hydrolysis rates of 2-arylpropionic esters catalyzed by Candida rugosa lipase 128
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice. 128
New solid-supported reagents (SSRs) for selective acylation of amines 127
A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward a1 adrenoceptors 127
Solid Phase Synthesis of 2,6-Disubstituted-4(3H)-pyrimidinones Targeting HIV-1 Reverse Transcriptase 126
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands 126
Solution-phase parallel synthesis of S-DABO analogues 126
Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure 125
Reducing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on alcohol self-administration in rats: Possible involvement of the GABAB receptor 125
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists 124
Stereoselective synthesis of α-aryl-2-benzofuranmethanamines and α-aryl-1H-indole-2-methanamines through palladium-mediated annulation of chiral α-arylpropargylamines 124
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. 124
Fibroblast growth factors and their inhibitors 123
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 2. Synthesis and Structure-Activity Relationship of Potent and Selective Cannabinoid-2 Receptor Agonists Endowed with Analgesic Activity in Vivo. 123
6-Vinyl pyrimidine and pyrimidinone derivatives and the use thereof 123
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 122
Rational design and synthesis of homochiral azole antifungal agents 122
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 122
Synthesis and biological evaluation of conformationally restricted analogs of tolmetin and ketorolac 121
The tetramerization of 2,4-dimethoxycinnamates. A novel route to calixarenes 121
Efficient synthesis of iminoctadine, a potent antifungal agent and polyamine oxidase inhibitor (PAO). 120
Cyclic Dipeptides - A Stereocontrolled Synthesis of (2s,3r,6r) and (2r,3r,6r)-6-tert-butoxycarbonylamino-3-methoxycarbonyl-2-methyl-5-oxope Rhydro-1,4-thiazepine 120
A new linker for anchoring/masking primary amines on solid support 119
Total Synthesis of δ-Sanshool and Analogues Thereof 118
Studies towards the synthesis of the bicyclic 3,8-secotaxanediterpenoid system using a ring closing metathesis strategy 118
The 4-Quinolone-3-carboxylic Acid Motif as a Multivalent Scaffold in Medicinal Chemistry 117
A pharmacophore modeling approach to design new taxol® mimics: towards the synthesis of potential anticancer and MDR-reversing agent 117
Three-Dimensional Quantitative Structure-Selectivity Relationships (3D-QSSR) Analysis Guided Rational Design of a Highly Selective Ligand for the Cannabinoid Receptor 2 116
' Exploring the Synthesis of Masked Phosphoramido 6-Vinylcytidine Derivatives as Building Blocks for Cross-Linking Oligonucleotides ' 116
Practical synthesis of novel purine analogues as Hsp90 inhibitors. 116
The bioisosteric concept applied to cannabinoid ligands 116
Stereoselective synthesis of advanced intermediates en route to Taxuspine U and X: a study of macrocyclization via ring closing metathesis to highly constrained twelve-membered rings. 115
Studies toward Taxuspine X, a potent Multidrug - Resistance Reversing Agent, via ring closing metathesis strategy 115
Parallel Solution-Phase and Microwave-Assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 112
A combinatorial approach for the solid phase synthesis of 5,6-disubstituted pyrimidinones and pyrimidine derivatives 111
Molecular modeling as a powerful technique for understanding small-large molecules interactions 111
Synthesis, biological evaluation and pharmacophore generation of uracil, 4(3H)-pyrimidinone, and uridine derivatives as potent and selective inhibitors of parainfluenza 1 (Sendai) virus 111
Enantioselective synthesis of 1-aryl-2-propenylamines: a new approach to a stereoselective synthesis of the Taxol® side chain. 111
Microwave-assisted ethylene-alkyne cross-metathesis: synthesis of chiral 2-(N-1-acetyl-1-arylmethyl)-1,3-butadienes 111
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors 110
Preparation of pyrimidine and pyrimidinone derivatives and their use for the treatment of HIV infections 110
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 110
Cyclic dipeptides. 4. On the Pummerer rearrangement of diastereomeric dehydrocyclolanthionine sulfoxides 110
Molecular modeling of azole antifungal agents active against Candida albicans .1. A comparative molecular field analysis study 110
Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase 110
3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones 108
Molecular Basis for the Binding of Competitive Inhibitors of Maize Polyamine Oxidase 108
Totale 13.747
Categoria #
all - tutte 61.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.165 0 0 0 0 0 0 0 0 0 0 601 564
2019/20204.192 584 150 255 685 282 300 302 516 329 366 138 285
2020/20213.302 174 325 45 345 134 402 190 486 408 317 297 179
2021/20222.268 174 336 145 219 59 70 135 81 85 261 208 495
2022/20233.386 225 225 469 488 329 713 71 278 349 67 106 66
2023/20242.138 127 41 167 143 89 591 853 73 13 40 1 0
Totale 21.170